530057 VIVANZA

Vivanza Biosciences Share Price

 

Stock Result Declared

 

Start SIP in VIVANZA

Start SIP

Performance

  • Low
  • ₹2
  • High
  • ₹2
  • 52 Week Low
  • ₹2
  • 52 Week High
  • ₹3
  • Open Price₹2
  • Previous Close₹2
  • Volume57,258
  • 50 DMA₹2.12
  • 100 DMA₹2.14
  • 200 DMA₹2.35

Investment Returns

  • Over 1 Month -4.02%
  • Over 3 Month -9.66%
  • Over 6 Month + 4.88%
  • Over 1 Year -7.33%

Smart Investing Starts Here Start SIP with Vivanza Biosciences for Steady Growth!

Invest Now

Vivanza Biosciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -56.2
  • PEG Ratio
  • 0.8
  • Market Cap Cr
  • 9
  • P/B Ratio
  • 1.9
  • Average True Range
  • 0.07
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.02
  • RSI
  • 53.19
  • MFI
  • 60.74

Vivanza Biosciences Financials

Vivanza Biosciences Technicals

EMA & SMA

Current Price
₹2.15
+ 0.1 (4.88%)
pointer
  • Bearish Moving Average 2
  • Bullish Moving Average 14
  • 20 Day
  • ₹2.10
  • 50 Day
  • ₹2.12
  • 100 Day
  • ₹2.14
  • 200 Day
  • ₹2.35

Resistance and Support

2.12 Pivot Speed
  • R3 2.26
  • R2 2.20
  • R1 2.18
  • S1 2.10
  • S2 2.04
  • S3 2.02

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Vivanza Biosciences has an operating revenue of Rs. 110.03 Cr. on a trailing 12-month basis. An annual revenue de-growth of -73% needs improvement, Pre-tax margin of -9% needs improvement, ROE of -17% is poor and needs improvement. The company has a debt to equity of 84%, which is bit higher. From an O'Neil Methodology perspective, the stock has an EPS Rank of 40 which is a POOR score indicating inconsistency in earnings, a RS Rating of 49 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 78 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Vivanza Biosciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-12 Quarterly Results
2025-11-11 Quarterly Results
2025-09-01 Others Inter-alia, to consider 1. Appoint Mr. Chintan K. Patel, Practicing Company Secretary as a Scrutinizer & Secretarial Auditors of the Company. 2. Draft notice of 43rd AGM. 3. Other business matters. split from Rs. 10/- to Re. 1/-.
2025-08-13 Quarterly Results
2025-05-12 Audited Results
Date Purpose Remarks
2023-03-24 Split Rs.0.00 split from Rs. 10/- to Re. 1/-.

Vivanza Biosciences F&O

Vivanza Biosciences Shareholding Pattern

20.02%
0%
73.42%
6.56%

About Vivanza Biosciences

  • NSE Symbol
  • VIVANZA
  • BSE Symbol
  • 530057
  • Managing Director
  • Mr. J A Mehta
  • ISIN
  • INE984E01035

Similar Stocks to Vivanza Biosciences

Vivanza Biosciences FAQs

Vivanza Biosciences share price is ₹2 As on 14 February, 2026 | 09:18

The Market Cap of Vivanza Biosciences is ₹8.6 Cr As on 14 February, 2026 | 09:18

The P/E ratio of Vivanza Biosciences is -56.2 As on 14 February, 2026 | 09:18

The PB ratio of Vivanza Biosciences is 1.9 As on 14 February, 2026 | 09:18

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23